Mare Nostrum Logo

Mare Nostrum

Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.

ALMAR | PA

Overview

Corporate Details

ISIN(s):
FR0013400835
LEI:
9695001D0TLYAWZSX187
Country:
France
Address:
9 AVENUE DE CONSTANTINE, 38100 GRENOBLE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe Mare Nostrum is a human resources engineering company with over 20 years of experience. The group specializes in a comprehensive range of HR solutions, including recruitment, temporary work, professional training, and wage portage (umbrella company services). Comprising over 190 employees, the company operates through 18 dedicated brands across five core areas of expertise. Groupe Mare Nostrum's strength lies in the complementarity of its businesses and services, enabling it to offer integrated and tailored HR support to its clients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 18:30
Earnings Release
MARE NOSTRUM - Résultats semestriels 2025
French 344.6 KB
2025-10-13 18:30
Transaction in Own Shares
MARE NOSTRUM finalise le recentrage de ses activités avec la cession de sa fili…
French 301.5 KB
2025-08-05 18:45
Legal Proceedings Report
MARE NOSTRUM : Nouvelle étape franchie - Approbation des plans de redressement …
French 282.1 KB
2025-07-21 18:30
Legal Proceedings Report
MARE NOSTRUM : Approbation du plan de continuation par le Tribunal de Commerce …
French 287.9 KB
2025-06-30 18:45
Legal Proceedings Report
MARE NOSTRUM : Approbation du projet de plan de continuation par les créanciers
French 308.8 KB
2025-06-18 18:00
Business and Financial Review
MARE NOSTRUM dévoile sa nouvelle politique de marques
French 346.4 KB
2025-06-16 19:15
Pre-Annual General Meeting Information
MARE NOSTRUM : Assemblée Générale Mixte du 30 juin 2025 - Mise à disposition d…
French 254.0 KB
2025-05-30 07:30
Legal Proceedings Report
MARE NOSTRUM : Projet de plan de continuation finalisé - Mise à disposition aup…
French 310.7 KB
2025-05-22 18:30
Earnings Release
MARE NOSTRUM : Chiffre d’affaires solide au 1er trimestre 2025 de 28 MEUR - Fin…
French 313.2 KB
2025-05-15 18:06
Earnings Release
MARE NOSTRUM : Résultats annuels 2024 - Amélioration des performances opération…
French 299.0 KB
2025-04-28 20:00
Report Publication Announcement
MARE NOSTRUM : Report de publication des résultats annuels et du Rapport financ…
French 264.4 KB
2025-01-22 18:00
Legal Proceedings Report
MARE NOSTRUM : Point d’étape sur la procédure - Prolongation exceptionnelle de …
French 265.6 KB
2025-01-14 18:00
Transaction in Own Shares
MARE NOSTRUM : Bilan du contrat de liquidité au 31 décembre 2024
French 281.5 KB
2025-01-06 18:30
Board/Management Information
MARE NOSTRUM : Renforcement de la division Travail Temporaire - Nomination d’un…
French 287.3 KB
2024-12-20 18:00
Legal Proceedings Report
MARE NOSTRUM : Point d’étape sur la procédure et entrée en discussion avec Domi…
French 295.9 KB

Automate Your Workflow. Get a real-time feed of all Mare Nostrum filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mare Nostrum

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mare Nostrum via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710

Talk to a Data Expert

Have a question? We'll get back to you promptly.